Cory R. Weissman, MD

  • 6Articles
  • 54.4KReads
  • 2018–2025Active
  • 30Collaborators
  • 255Citations

About

Cory R. Weissman, MD, is affiliated with the Department of Psychiatry at the University of California San Diego. With publications spanning from 2018 to 2025, Weissman has contributed extensively to research on suicidality, depression, and the therapeutic use of psychedelics. The author’s work includes systematic reviews and meta-analyses on inpatient suicidality treatment, repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression, and the effects of psychedelic therapy on suicidal ideation. Frequent collaborators include Daniel M. Blumberger, Zafiris J. Daskalakis, and Benoit H. Mulsant.

Publications

JCP
Inpatient Treatment of Suicidality
Systematic Review

Inpatient Treatment of Suicidality

January 8, 2025

Effective, rapid treatments that target suicidality in psychiatric inpatients are scarce in the existing literature and in clinical practice, underscoring the need for studies to identify and validate these...
, , , et al
JCP
rTMS for Treatment-Resistant Depression: Mismatch of Evidence and Insurance Coverage Policies
Commentary

rTMS for Treatment-Resistant Depression: Mismatch of Evidence and Insurance Coverage Policies

April 26, 2023

The authors argue that insurance companies’ prior authorization process overly restricts access to rTMS, which has proven effectiveness for TRD.
, , , et al
JCP
Corrigendum to “Decreases in Suicidality Following Psychedelic Therapy: A Meta-Analysis of Individual Patient Data Across Clinical Trials”
Letter to the Editor

Corrigendum to “Decreases in Suicidality Following Psychedelic Therapy: A Meta-Analysis of Individual Patient Data Across Clinical Trials”

May 9, 2022

The authors note two suicidality-related events that occurred within the studies included in their recent meta-analysis.
, , , et al
JCP
Meta-Analysis

Psychedelic Therapy and Suicidality

January 18, 2022

Psychedelic therapy shows promise for a range of mental health concerns, including suicidality. This meta-analysis is the first to systematically examine the effects of psychedelic therapy on suicidality.
, , , et al
JCP
Meta-Analysis

Effect of rTMS on Suicidal Ideation in Treatment-Resistant Depression

January 18, 2022

Repetitive magnetic transcranial stimulation (rTMS) has been established as an efficacious treatment for MDD. This meta-analysis looked at its effects on suicidal ideation in depressed patients across the lifespan.
, , , et al
JCP
Original Research

Does rTMS Decrease Suicidal Ideation?

April 17, 2018

Read a study on the effects of rTMS on suicidal ideation in patients with treatment-resistant major depression (TRD).
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe